Search

Your search keyword '"Knight, Daniel S."' showing total 160 results

Search Constraints

Start Over You searched for: Author "Knight, Daniel S." Remove constraint Author: "Knight, Daniel S."
160 results on '"Knight, Daniel S."'

Search Results

1. Deep phenotyping of p.(V142I)‐associated variant ATTR amyloid cardiomyopathy: distinct from wild‐type ATTR amyloidosis?

6. Myocardial Edema and Prognosis in Amyloidosis

7. Conventional heart failure therapy in cardiac ATTR amyloidosis

8. Recurrent episodes of Takotsubo cardiomyopathy in systemic sclerosis

10. COVID-19: Myocardial Injury in Survivors

13. Cardiovascular magnetic resonance in light-chain amyloidosis to guide treatment

14. Distinct cardiovascular phenotypes are associated with prognosis in systemic sclerosis: a cardiovascular magnetic resonance study

15. Distinct cardiovascular phenotypes are associated with prognosis in systemic sclerosis: a cardiovascular magnetic resonance study.

16. Ongoing Exercise Intolerance Following COVID‐19: A Magnetic Resonance–Augmented Cardiopulmonary Exercise Test Study

17. Non-invasive characterization of pleural and pericardial effusions using T1 mapping by magnetic resonance imaging

21. Non-invasive characterization of pleural and pericardial effusions using T1 mapping by magnetic resonance imaging.

24. Cardiac Magnetic Resonance–Derived Extracellular Volume Mapping for the Quantification of Hepatic and Splenic Amyloid

27. Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance

28. COVID-19

29. The Authors Reply

30. Noncontrast Magnetic Resonance for the Diagnosis of Cardiac Amyloidosis

31. Anakinra treats fulminant myocarditis from Neisseria meningitidis septicaemia and haemophagocytic lymphohistiocytosis: a case report.

32. Native T1 and Extracellular Volume in Transthyretin Amyloidosis

33. Cardiac Structural and Functional Consequences of Amyloid Deposition by Cardiac Magnetic Resonance and Echocardiography and Their Prognostic Roles

34. Redefining viability by cardiovascular magnetic resonance in acute ST-segment elevation myocardial infarction

37. CMR-Verified Regression of Cardiac AL Amyloid After Chemotherapy

38. Prospective comparison of novel dark blood late gadolinium enhancement with conventional bright blood imaging for the detection of scar

40. Quantification of both the area-at-risk and acute myocardial infarct size in ST-segment elevation myocardial infarction using T1-mapping

41. Full left ventricular coverage is essential for the accurate quantification of the area-at-risk by T1 and T2 mapping

42. Magnetic Resonance in Transthyretin Cardiac Amyloidosis

44. 024 Spectrum and significance of CMR findings in cardiac transthyretin amyloidosis

45. 008 Demonstration of cardiac AL amyloidosis regression after succesful chemotherapy. a CMR study

46. 001 Multiparametric mapping to understand pathophysiology in cardiac amyloidosis

47. 028 Routine identification of hypoperfusion in cardiac amyloidosis by myocardial blood flow mapping

Catalog

Books, media, physical & digital resources